EYPT · NASDAQ · Biotechnology

EyePoint (EYPT)

Develops sustained-release retinal therapies built around DURAVYU and Durasert E technology.

$4.07
After hours0.00 (0.00%)
At close$4.07(+1.24%)

13F · 13D/G · Form 4

Institutions≈ 107.13%92.36M shares
209 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail
Insiders0.84%726.5K shares
5 holders · as of Aug 24, 2026
Strategic holders16.42%14.16M shares
2 holders · as of Sep 8, 2026
Adds to124.39%

86.21M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.

These groups come from separate filings that can overlap, so they add to 124.39%; nothing is left for Other.

13F · 13D/G · Form 4

HolderStakeSharesDate
JANUS HENDERSON GROUP Ltd.Strategic
10.86%9.37Mfiled Sep 8, 2026
Suvretta Capital Management, LLCInstitution
9.62%8.30Mas of Jun 30, 2026
BlackRock, Inc.Institution
8.66%7.46Mas of Jun 30, 2026
Cormorant Asset Management, LPInstitution
8.12%7.00Mas of Jun 30, 2026
Federated Hermes, Inc.Institution
6.59%5.68Mas of Jun 30, 2026
Adage Capital Partners GP, L.L.C.Institution
5.60%4.83Mas of Jun 30, 2026
Franklin Resources IncInstitution
5.58%4.81Mas of Jun 30, 2026
Adage Capital Management, L.P.1Strategic10 percent owner
5.56%4.79Mfiled Aug 12, 2026
Commodore Capital LPInstitution
5.34%4.60Mas of Jun 30, 2026
Jupiter Topco LLCInstitution
4.37%3.77Mas of Jun 30, 2026
Vanguard Capital Management LLCInstitution
4.21%3.63Mas of Jun 30, 2026
Paradigm Biocapital Advisors LPInstitution
3.35%2.89Mas of Jun 30, 2026
State Street CorpInstitution
2.73%2.36Mas of Jun 30, 2026
Geode Capital Management, LLCInstitution
2.39%2.06Mas of Jun 30, 2026
Abrdn PLCInstitution
2.33%2.01Mas of Jun 30, 2026
Citadel Advisors LLCInstitution
2.29%1.98Mas of Jun 30, 2026
Balyasny Asset Management L.P.Institution
2.10%1.81Mas of Jun 30, 2026
Parkman Healthcare Partners LLCInstitution
1.49%1.29Mas of Jun 30, 2026
Eventide Asset Management, LLCInstitution
1.44%1.25Mas of Jun 30, 2026
Two Sigma Investments, LPInstitution
1.37%1.18Mas of Jun 30, 2026
Essex Woodlands Management, Inc.Institution
1.26%1.08Mas of Jun 30, 2026
Orbimed Advisors LLCInstitution
1.24%1.07Mas of Jun 30, 2026
5Am Venture Management, LLCInstitution
1.22%1.05Mas of Jun 30, 2026
Rosalind Advisors, Inc.Institution
1.15%988,230as of Jun 30, 2026
Vanguard Portfolio Management LLCInstitution
1.13%971,014as of Jun 30, 2026
  1. Adage Capital Management, L.P.'s own ownership statement (13G, Aug 12, 2026) reports fewer shares than the transaction reports; the statement is used.

13F, as of Jun 30, 2026

209 holders · 92.36M shares · 27 new positions · 92 increased · 64 reduced · 23 closed

HolderShares% outstandingChg q/qFiled
Suvretta Capital Management, LLC8.30M9.62%0Aug 14, 2026
BlackRock, Inc.7.46M8.66%+285.9KAug 7, 2026
Cormorant Asset Management, LP7.00M8.12%−1.27MAug 14, 2026
Federated Hermes, Inc.5.68M6.59%+11.5KAug 12, 2026
Adage Capital Partners GP, L.L.C.4.83M5.60%+1.53MAug 14, 2026
Franklin Resources Inc4.81M5.58%−241.5KAug 13, 2026
Commodore Capital LP4.60M5.34%+1.78MAug 14, 2026
Jupiter Topco LLC3.77M4.37%+3.77MnewAug 14, 2026

13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
JANUS HENDERSON GROUP Ltd.10.90%9.37M13GSep 8, 2026
Cormorant Asset Management, LP9.98%8.27M13GDec 8, 2025
BlackRock, Inc.7.80%4.16MOct 22, 2024
Federated Hermes, Inc.6.68%4.60M13GJul 8, 2025
Franklin Resources, Inc.6.10%4.14M13GJan 27, 2025
Adage Capital Management, L.P.5.71%4.79M13GAug 12, 2026
TCG Crossover Fund II, L.P.incl. Chen Yu, TCG Crossover GP II, LLC5.20%3.57M13GNov 7, 2024
Vanguard Capital Management5.03%4.22M13GJul 31, 2026

Form 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Aug 18, 2026
Karen L. Zaderejdirector
Purchase10,600$4.9349,100
Jun 30, 2026
Ramiro Ribeiroofficer: Chief Medical Officer
Sale · 2 lots4,875$15.010
Apr 17, 2026
Ramiro Ribeiroofficer: Chief Medical Officer
Sale2,437$15.000
Mar 16, 2026
Jay S. Dukerdirector, officer: President and CEO
Purchase1,500$13.15100,665
Mar 4, 2026
Ramiro Ribeiroofficer: Chief Medical Officer
Sale2,438$17.870
Feb 17, 2026
Ramiro Ribeiroofficer: Chief Medical Officer
Sale2,437$15.000
Jan 5, 2026
Ramiro Ribeiroofficer: Chief Medical Officer
Sale42,544$17.100
Dec 4, 2025
Cormorant Asset Management, LPother: Former 10% Owner
Sale60,000$15.708,265,000
Dec 4, 2025
Nancy Lurkerdirector
Sale9,300$15.11206,547
Nov 28, 2025
Nancy Lurkerdirector
Sale500$14.95215,847

House and Senate disclosures

Not reported.